Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...

Podrobná bibliografie
Hlavní autoři:	Alton, E, Beekman, J, Boyd, A, Brand, J, Carlon, M, Connolly, M, Chan, M, Conlon, S, Davidson, H, Davies, J, Davies, L, Dekkers, J, Doherty, A, Gea-Sorli, S, Gill, D, Griesenbach, U, Hasegawa, M, Higgins, T, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Innes, J, Maher, T, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Schmidt, A, Stevenson, B, Sumner-Jones, S, Toshner, R, Tsugumine, S, Wasowicz, M, Zhu, J
Médium:	Journal article
Jazyk:	English
Vydáno:	BMJ Publishing Group 2016

Podobné jednotky

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
Autor: Griesenbach, U, a další
Vydáno: (2016)

Moving lentiviral-based gene therapy into a first-in-man CF trial
Autor: Griesenbach, D, a další
Vydáno: (2015)

Towards a first-in-human trial with a pseudotyped lentivirus
Autor: Alton, EW, a další
Vydáno: (2020)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
Autor: Hyde, S, a další
Vydáno: (2015)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
Autor: Griesenbach, U, a další
Vydáno: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
Autor: Griesenbach, U, a další
Vydáno: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
Autor: Griesenbach, U, a další
Vydáno: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Autor: Alton, E, a další
Vydáno: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
Autor: Alton, E, a další
Vydáno: (2014)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
Autor: Palau, H, a další
Vydáno: (2019)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
Autor: Paul-Smith, M, a další
Vydáno: (2017)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
Autor: Alton, E, a další
Vydáno: (2012)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
Autor: Alton, E, a další
Vydáno: (2012)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
Autor: Lund-Palau, H, a další
Vydáno: (2018)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
Autor: Paul-Smith, M, a další
Vydáno: (2018)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
Autor: Lund-Palau, H, a další
Vydáno: (2018)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
Autor: McLachlan, G, a další
Vydáno: (2004)

Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
Autor: Pytel, K, a další
Vydáno: (2016)

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy
Autor: Davidson, H, a další
Vydáno: (2008)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
Autor: McLachlan, G, a další
Vydáno: (2011)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
Autor: Griesenbach, U, a další
Vydáno: (2011)

Caprine lentivirus in sheep milk and semen
Autor: C.C.V. Lima, a další

An immunocytochemical assay to detect human CFTR expression following gene transfer.
Autor: Davidson, H, a další
Vydáno: (2009)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
Autor: Sergijenko, A, a další
Vydáno: (2020)

Genetic medicines for CF: Hype versus reality
Autor: Alton, E, a další
Vydáno: (2016)

A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.
Autor: Gifford, R, a další
Vydáno: (2008)

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
Autor: Sumner-Jones, S, a další
Vydáno: (2009)

Gene therapy for respiratory diseases; progress and a changing context
Autor: Alton, EWFW, a další
Vydáno: (2020)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
Autor: Gill, DR, a další
Vydáno: (2010)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
Autor: Alton, E, a další
Vydáno: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
Autor: Alton, E, a další
Vydáno: (2013)

Discovery and analysis of the first endogenous lentivirus
Autor: Katzourakis, A, a další
Vydáno: (2007)

Discovery and analysis of the first endogenous lentivirus.
Autor: Katzourakis, A, a další
Vydáno: (2007)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
Autor: Davies, J, a další
Vydáno: (2009)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
Autor: Davies, J, a další
Vydáno: (2009)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
Autor: Davies, G, a další
Vydáno: (2011)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
Autor: Davies, J, a další
Vydáno: (2011)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
Autor: Alton, E, a další
Vydáno: (2013)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
Autor: Alton, E, a další
Vydáno: (2012)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
Autor: Alton, E, a další
Vydáno: (2013)